Navigation Links
Partial-match cell transplants for kids with resistant leukemia

Children with most resistant leukemia can be treated with a superior method of blood stem cell transplantations, when regular treatment fails, as showed by the clinicians at the St. Jude Children's Research Hospital. //

The St. Jude technique allows blood stem cells to come from parents or unmatched adult siblings; and it avoids the aggressive, toxic treatments that usually must accompany the transplant. This allows the majority of patients with leukemia or non-cancerous blood disorders to receive a transplant, according to Gregory Hale, M.D., St. Jude Bone Marrow Transplantation Division interim chief. A report on this work appears in the prepublication edition of the British Journal of Haematology.

A clinical trial of this technique demonstrated that it accelerated recovery of the immune system in recipients and shortened the duration of immune deficiency during the early post-transplant period, reducing the risk of infections. The immune system recovery included not only T and B lymphocytes, the major cells genetically programmed to attack specific targets, but also natural killer cells, a critical first-response army of cells that acts as a quick-strike force against a wide variety of targets.

"The overall success of this procedure suggests it holds promise for children who are likely to fail standard treatment for leukemia because they have treatment-resistant disease and no matched donor," Hale said.

The key to the St. Jude strategy--reduced intensity conditioning regimen (RICR)--is that it avoids the total-body irradiation routinely used to kill the recipient's own stem cells to make way for the transplantation. RICR also avoids the use of anti-thymocyte globulin (ATG), a drug commonly used to suppress the remaining immune system of recipients in order to reduce the chance they will reject the transplanted blood stem cells. ATG often delays rebuilding of the immune system in transplant recipients and can lead to a vir
'"/>




Page: 1 2 3

Related medicine news :

1. Parasite infections linked to organ transplants
2. Cell transplants used to fend off Parkinsons symptoms
3. Bone marrow transplants for limbs
4. Cell transplants for stroke
5. More risks connected with live-donor liver transplants
6. Baltimore doctors perform three simultaneous kidney transplants
7. Skin cancer linked to usage of Drug Azathioprine in organ transplants
8. Innovative solution to help reduce the waiting times for kidney transplants
9. Islet cell transplants for Type 1 Diabetes
10. Flaws Reported in overview of US organ transplants
11. African HIV strains more resistant to anti HIV drugs
Post Your Comments:
Breaking Medicine News(10 mins):Health News:Abortion, Bishops, and Healthcare: Announcing 'Deaf at the Cathedral' Tour in Nine States. 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 2Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 3Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 4Health News:LodgeNet Interactive to Participate in UBS' 37th Annual Global Media and Communications Conference 5Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 2Health News:Ifbyphone's Virtual Call Center Software Saves DiabetesAmerica Over $240,000 Per Year 3Health News:LCA-Vision Joins Forces With the Wounded Warrior Project to Give the Gift of Enhanced Vision to Wounded American Heroes 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 2Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 3Health News:Moses Cone Health System Selects Streamline Health to Enhance the Electronic Medical Record 4
Other Medicine News:Health News:AMN Healthcare Reports Second Quarter 2008 Results 2Health News:AMN Healthcare Reports Second Quarter 2008 Results 3Health News:AMN Healthcare Reports Second Quarter 2008 Results 4Health News:AMN Healthcare Reports Second Quarter 2008 Results 5Health News:AMN Healthcare Reports Second Quarter 2008 Results 6Health News:AMN Healthcare Reports Second Quarter 2008 Results 7Health News:AMN Healthcare Reports Second Quarter 2008 Results 8Health News:AMN Healthcare Reports Second Quarter 2008 Results 9Health News:AMN Healthcare Reports Second Quarter 2008 Results 10Health News:AMN Healthcare Reports Second Quarter 2008 Results 11Health News:AMN Healthcare Reports Second Quarter 2008 Results 12Health News:AMN Healthcare Reports Second Quarter 2008 Results 13Health News:Washington Dental Service Encourages Dental Checkups as Part of Back-to-School Routine 2Health News:Washington Dental Service Encourages Dental Checkups as Part of Back-to-School Routine 3Health News:Ortho-McNeil initiates first-of-its-kind skin infection registry 2Health News:Americans Drinking Less Alcohol 2Health News:Comar, Inc. Launches AccuCup(TM) - A Printed Dosage Cup for Use in General and Pediatric Markets 2Health News:Researchers Find Genes That Influence West Nile Virus 2Health News:Researchers Find Genes That Influence West Nile Virus 3
Breaking Medicine Technology:Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 2Baxa Features DoseEdge(TM) Pharmacy Workflow Manager at the ASHP Midyear Clinical Meeting 3HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 2HealthSport, Inc. Closes Stock Purchase Agreement With SMI Manufacturing - Receives $2.5 Million 3Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 1Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 2Data Released at an International Stem Cell Meeting Highlights Effectiveness of New Patient Education System Developed to Support Federal and State Gu 58183 3Right to Health Care Debated at New ProCon org Website 58181 1Right to Health Care Debated at New ProCon org Website 58181 2R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 1R Kerry Clark and Robert J Palmisano Join Bausch 26 Lomb Board of Directors 58179 2